In the last 12 months, insiders at ENZON PHARMACEUTICALS, INC. ($ENZN) filed 5 transactions with the SEC: 2 open-market purchases totaling $13,909 and 0 sales totaling $0. Net insider sentiment: net buying.
ENZON PHARMACEUTICALS, INC. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- READ RANDOLPH C (Director) — 2 transactions totaling $13,909
- ICAHN CARL C (TenPercentOwner) — 3 transactions totaling $0
View all SEC Filings for ENZON PHARMACEUTICALS, INC. (ENZN).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2026 | ICAHN CARL C | TenPercentOwner | D | Preferred Stock | 39277 | $0.00 | 0.0000 | 74,215,000 | 100.00% | 0.05% |
| March 25, 2026 | ICAHN CARL C | TenPercentOwner | A | Common Stock | 5658396 | $0.00 | 6,018,962.0000 | 74,215,000 | 1569.31% | 7.62% |
| March 26, 2026 | ICAHN CARL C | TenPercentOwner | A | Common Stock | 7407489 | $0.00 | 13,426,451.0000 | 74,215,000 | 123.07% | 9.98% |
| June 14, 2023 | READ RANDOLPH C | Director | P | Common Stock | 15000 | $0.13 | 115,450.0000 | 74,215,000 | 14.93% | 0.02% |
| June 16, 2023 | READ RANDOLPH C | Director | P | Common Stock | 84550 | $0.14 | 200,000.0000 | 74,215,000 | 73.24% | 0.11% |